Adial Pharmaceuticals, Inc. Accounts Payable
Adial Pharmaceuticals, Inc. (ADIL) had Accounts Payable of $2.62 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $2.62M.
- 2026-03-31: Accounts Payable, Current $573.57K.
- 2025-12-31: Accounts Payable, Current $655.00K; Accounts Payable, Current as first filed $655.21K.
- 2025-09-30: Accounts Payable, Current $556.28K.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.62M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $573.57K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $655.00K 10-Q · filed 2026-08-14 | $655.21K 10-K · filed 2026-03-05 |
| 2025-09-30 | $556.28K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $671.12K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $532.43K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $250.13K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $318.12K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $316.73K 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $103.33K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $81.92K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $111.70K 10-Q/A · filed 2023-10-30 | |
| 2023-03-31 | $530.14K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $276.41K 10-K · filed 2024-04-01 | $393.83K 10-K · filed 2023-03-30 |
| 2022-09-30 | $278.20K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $617.78K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $415.09K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $286.19K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $185.19K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $477.41K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $637.40K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $648.74K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $247.40K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $442.38K 10-Q · filed 2020-08-13 | |
| 2019-12-31 | $190.20K 10-K · filed 2021-03-22 | |
| 2019-09-30 | $475.09K 10-Q · filed 2019-11-14 | |
| 2018-12-31 | $99.67K 10-K · filed 2020-03-20 | $82.68K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |